Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26167780 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Meritxell Perramón und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 …. Hauptthemen laut MEDLINE: Translational Research, Biomedical, Liver Cirrhosis, Liver, Tissue Culture Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR, MCIN/AEI/10.13039/501100011033/ and by FEDER Una manera de hacer Europa, Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, "A way to make Europe.
Abstract (Originalsprache)
Halting liver fibrosis progression is a key goal in treating liver disease, yet effective antifibrotic drugs remain unavailable. This study explores the use of precision-cut liver slices (PCLS) as an ex vivo model to evaluate new therapies. Researchers tested how different oxygen levels affect viability, tissue integrity, and inflammatory response in PCLS from healthy and fibrotic rats. Fibrotic PCLS maintained their pathological gene signature under 40% oxygen and responded to inflammatory stimuli, indicating preserved functionality. Exposure to high oxygen levels increased oxidative stress and pro-inflammatory gene expression. Cirrhotic PCLS showed early signs of reduced viability and the upregulation of fibrosis-related genes including Col1α2, Col3α1, αSMA, Timp1, Timp2, Mmp2, Pdgfrβ, Nos2, Cox2, and Il6. Lipopolysaccharide (LPS) exposure induced the marked overexpression of Nos2 and Il1β mRNA and confirmed the model’s responsiveness to external injury. Fibrotic PCLS retained fibrogenic activity for at least 48 h. Additionally, the adenoviral delivery of a dominant-negative soluble PDGFRβ effectively blocked fibrotic signaling. Human fibrotic PCLS also remained viable for 72 h and showed an increased mRNA expression of fibrosis markers such as COL1A1, αSMA, and MMP2. These results highlight the potential of PCLS as a promising platform for future therapeutic testing, pending further validation with functional interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry and Molecular Genetics Service, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), ISCIII, 28029 Madrid, Spain.
- Department of Biomedicine, University of Barcelona, 08036 Barcelona, Spain.
- Hepatopancreatobiliary Surgery & Transplantation, General & Digestive Surgery Service, Digestive & Metabolic Disease Institute (ICMDM), Hospital Clínic of Barcelona, 08036 Barcelona, Spain.
- Department of Medicine, University of Barcelona, 08036 Barcelona, Spain.
ORCID-Profile: Meritxell Perramón, Wladimiro Jiménez, Guillermo Fernández-Varo
Förderung
- MCIN/AEI/10.13039/501100011033 and by the European Union Next Generation EU/PRTR
- MCIN/AEI/10.13039/501100011033/ and by FEDER Una manera de hacer Europa
- Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, "A way to make Europe
- Instituto de Salud Carlos III and by the European Regional Development Fund, European Union, “A way to make Europe
- RedFibro
- The Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), funded by the Instituto de Salud Carlos III
Zitieren
APA
Perramón, M., Macías-Herranz, M., García-Pérez, R., Jiménez, W., & Fernández-Varo, G. (2025). Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167780
Vancouver
Perramón M, Macías-Herranz M, García-Pérez R, Jiménez W, Fernández-Varo G. Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167780
BibTeX
@article{Perramn2025,
author = {Perramón, Meritxell and Macías-Herranz, Manuel and García-Pérez, Rocío and Jiménez, Wladimiro and Fernández-Varo, Guillermo},
title = {Precision-Cut Liver Slices: A Valuable Preclinical Tool for Translational Research in Liver Fibrosis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26167780}
}
EUVIMED